Want to join the conversation?
According to $MRK, the company winning the breakthrough therapy designation and PRIME for its Ebola Zaire vaccine V920 indicate it has won the required approval to start the development & review of the drug candidate. To be accepted for PRIME, a medicine has to show its potential to benefit patients with unmet medical needs based on early data.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.